1 / 37

Ventilation/Non-Dialytic Therapies in the Paediatric BMT Patient Desmond Bohn

Ventilation/Non-Dialytic Therapies in the Paediatric BMT Patient Desmond Bohn The Department of Critical Care Medicine, The Hospital for Sick Children, Toronto. Paediatric BMT and Critical Care. Sepsis Respiratory Airway obstruction Pneumonia/pneumonitis Pulmonary haemorrhage

jwheat
Télécharger la présentation

Ventilation/Non-Dialytic Therapies in the Paediatric BMT Patient Desmond Bohn

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Ventilation/Non-Dialytic Therapies in the Paediatric BMT Patient Desmond Bohn The Department of Critical Care Medicine, The Hospital for Sick Children, Toronto

  2. Paediatric BMT and Critical Care Sepsis Respiratory Airway obstruction Pneumonia/pneumonitis Pulmonary haemorrhage Interstitial pneumonitis ARDS Neurological Seizures Intracranial haemorrhage

  3. Paediatric BMT and Critical Care Hepatic failure Venocclusive disease GVHD Renal failure Drug nephrotoxicity Cardiac failure Drug toxicity

  4. ICU outcomes in paediatric BMT patients Diaz de Heredia C Bone Marrow Transplantation 1999; 24:163-168 31/176 patients admitted to ICU post BMT - 18% n BMT BMT allogenic autologous ARF 15 10 5 Septic shock 5 3 2 Neurological disorders 5 5 Heart failure 2 2 Others 4 2 2 26 patients underwent mechanical ventilation - survival 46%

  5. BAL in ventilated and non-ventilated in children after BMT Ben-Ari J Bone Marrow Transplantation 2001; 27:191 non-ventilated ventilated

  6. Diffuse alveolar hemorrhage in pediatric BMT patients Heggen J Pediatrics 2002; 109:965

  7. Diffuse alveolar hemorrhage in pediatric BMT patients Heggen J Pediatrics 2002; 109:965

  8. Diffuse alveolar haemorrhage in BMT patients • Presents with cough and tachypneoa • No underlying infective aetiology • Pulmonary haemorrhage on BAL • Usually occurs following engraftment • Incidence 5 - 10% • Characterised by thrombocytopoenia but normal coagulation • Treated with high dose steroids and PEEP • High mortality

  9. Markers of oxygenation defect PaO2/FiO2 < 200 = ARDS Oxygenation Index MAP x FiO2 x 100 >15 = severe ARDS PaO2

  10. Lung recruitment in ARDS

  11. Goals: 1. Avoid Overdistention 2. Avoid Underinflation 3. Keep the lung open 4. Reduce FiO2 Froese AB, Crit Care Med 1997; 25:906

  12. Responses of baboons to prolonged hyperoxia Fracica PJ J Appl Physiol 1991; 71:2352 normal lethal toxicity - FiO2 1.0 for 110 h alveolus PMN interstitial matrix PMN alveolus PMN interstitial matrix alveolus alveolus

  13. Pulmonary oxygen toxicity Davis WB N Engl J Med 1983; 309:878 FiO2 0.9 for 17 hrs in healthy humans

  14. VOLUME 342 MAY 4, 2000 NUMBER 18 VENTILATION WITH LOWER TIDAL VOLUMES AS COMPARED WITH TRADITIONAL TIDAL VOLUMES FOR ACUTE LUNG INJURY AND THE ACUTE RESPIRATORY DISTRESS SYNDROME THE ACUTE RESPIRATORY DISTRESS SYNDROME NETWORK

  15. Surfactant in ARDS Willson D Crit Care Med 1999; 27:188 Infasurf Surfactant proteins B & C 42 children with ARDS

  16. Control iNO Nitric oxide in ARDS Dobyns EL J Pediatr 1999;134:406 60 10 50 5 * 4 hours 12 hrs 0 40 * Change in P/F ratio from baseline Change in OI from baseline 30 -5 20 -10 * * -15 10 0 -20 4 hours 12 hrs

  17. Nitric oxide in ARDS n=40 n=177 n=30 Michael JR Am J Respir Crit Care Med 1999; 157:1372 Dellinger RP Crit Care Med 1998; 26:15 Troncy E Am J Respir Crit Care Med 1997; 157:1483

  18. Nitric oxide in ARDS 5 RCTs in adults 3 case series and 2 RCTs in pediatrics Physiological endpoints - improved oxygenation & reduction in PAP 40 - 60% of patients are “responders” No data suggests any improvement in outcome

  19. Steroids in ARDS MeduriGU JAMA 1998; 280:159 MODS Score Outcome

  20. Effect of prone position on survival in ARDS Gattinoni L N Engl J Med 2001; 345:568

  21. Effect of prone position on survival in ARDS Gattinoni L N Engl J Med 2001; 345:568

  22. RCT of prone vs supine ventilation in ARDS/ALI Gattinoni L N Engl J Med 2001; 345:568 304 patients randomised in 3 yrs Mortality (%) Supine Prone Intention to treat End of study 25 21 ICU discharge 48 50.7 Prone vs supine protocol End of study 27 22 ICU discharge 49.3 52.2 *Patients with P/F <88 40 20

  23. HFOV in Paediatric ARDS Arnold J. Crit Care Med 1994; 22:1530 CMV HFOV No. of patients 29 29 Duration of CMV 80 ± 81 143 ± 240 FiO2 0.83 ± 0.18 0.84 ± 0.15 PEEP 21 ± 5 22 ± 3 OI 29 ± 14 26 ± 10

  24. Algorithm for the use of HFOV MAP >5 cmH2O above CMV setting (25-30 cmH2O) High FiO2 (>0.8) Maintain MAP for 10-15 mins Attempt to decrease FiO2 yes no Decrease FiO2 in increments to <0.6 Increase the MAP in increments of 2 cmH2O Response usually at 30-35 cmH20

  25. Oxygen extraction ratio = (CaO2 - CvO2)/CaO2 . VO2 = Q x (CaO2 - CvO2) Oxygen delivery/consumption DO2 = Q x CaO2 . As DO2 decreases VO2 maintained by increased extraction

  26. Published outcomes in paediatric BMT patients admitted to ICU Number of Number Survival BMTs ventilated ventilated patients Lamas 1991-2000 151 34 5(23%) Hagen 1990-99 - 86 32(37%) Jacobe 1994-98 210 36 15 (41%) Keenan 1983-96 1080 121 19(16%) Rossi 1986-95 355 39 17(44%) Warwick 1976-92 869 196 79(40%) Diaz de Heredia 1991-95 176 26 12(46%) Hayes 1987-97 367 33 5(15%) Nichols 1978-88 23 2(9%) Bojko 1986-93 43 5(12%) Todd 1973-90 54 6(11%)

  27. AHRF: an integrated approach Pressure control ventilation (PIP <35 cmH2O) Negative fluid balance (furosimide) HFOV Prone position ventilation iNO 5 -20 ppm ?ECMO

  28. Prognosis of paediatric BMT patients requiring ventilation Rossi R Crit Care Med 1999; 27:1181 n = 41

  29. Prognosis of paediatric BMT patients requiring PPV Rossi R Crit Care Med 1999; 27:1181

  30. Ventilation in paediatric BMT patients Hagen SA Pediatric Crit Care Med 2003; 4:206

  31. Ventilation in paediatric BMT patients Hagen SA Pediatric Crit Care Med 2003; 4:206

  32. Ventilation/Non-Dialytic Therapies in the Paediatric BMT Patient Acute respiratory failure requiring PPV in the BMT patient is associated with a high mortality Therapy should be focused on minimising ventilation induced lung injury Ventilation strategies that improve oxygenation may not improve O2 delivery The development of hepato-renal failure is almost universally fatal

More Related